Compare NREF & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NREF | QSI |
|---|---|---|
| Founded | 2019 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 253.6M | 273.7M |
| IPO Year | 2020 | N/A |
| Metric | NREF | QSI |
|---|---|---|
| Price | $14.42 | $1.27 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $14.75 | $2.88 |
| AVG Volume (30 Days) | 64.6K | ★ 4.2M |
| Earning Date | 10-30-2025 | 11-05-2025 |
| Dividend Yield | ★ 14.07% | N/A |
| EPS Growth | ★ 132.43 | N/A |
| EPS | ★ 3.08 | N/A |
| Revenue | ★ $151,560,000.00 | $3,177,000.00 |
| Revenue This Year | $23.96 | N/A |
| Revenue Next Year | N/A | $159.68 |
| P/E Ratio | $4.62 | ★ N/A |
| Revenue Growth | ★ 107.15 | 40.20 |
| 52 Week Low | $12.14 | $0.95 |
| 52 Week High | $16.80 | $5.77 |
| Indicator | NREF | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 46.31 | 39.79 |
| Support Level | $14.25 | $1.18 |
| Resistance Level | $14.64 | $1.31 |
| Average True Range (ATR) | 0.26 | 0.10 |
| MACD | -0.08 | 0.00 |
| Stochastic Oscillator | 0.93 | 22.22 |
NexPoint Real Estate Finance Inc is a real estate investment trust. The company provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.